| | COMPOUND: C06849 | |
Entry |
|
Name |
|
Formula |
C18H29NO3
|
Exact mass |
307.2147
|
Mol weight |
307.4278
|
Structure |
|
Remark |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C07 BETA BLOCKING AGENTS
C07A BETA BLOCKING AGENTS
C07AB Beta blocking agents, selective
C07AB05 Betaxolol
D07526 Betaxolol (INN)
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS
S01ED Beta blocking agents
S01ED02 Betaxolol
D07526 Betaxolol (INN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01466 Adrenergic receptor antagonist
DG01464 beta-Adrenergic receptor antagonist (Beta blocker)
DG01461 beta1-Adrenergic receptor antagonist
DG00315 Betaxolol
D07526 Betaxolol
DG03231 Antihypertensive
DG00315 Betaxolol
D07526 Betaxolol
Ophthalmic agent
DG03201 Intraocular pressure lowering agent
DG00315 Betaxolol
D07526 Betaxolol
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
ADRB1
D07526 Betaxolol (INN)
|
Other DBs |
|
KCF data |
ATOM 22
1 C8y C 26.2401 -16.2421
2 C8x C 25.0228 -16.9327
3 C8x C 26.2518 -14.8433
4 O2a O 27.4459 -16.9504
5 C8x C 23.8170 -16.2304
6 C8x C 25.0403 -14.1350
7 C1b C 28.6632 -16.2597
8 C8y C 23.8229 -14.8257
9 C1c C 29.8690 -16.9679
10 C1b C 22.6114 -14.1293
11 C1b C 31.0863 -16.2772
12 O1a O 29.8630 -18.3726
13 C1b C 21.3998 -14.8257
14 N1b N 32.2979 -16.9853
15 O2a O 20.1825 -14.1293
16 C1c C 33.5152 -16.2947
17 C1b C 18.9710 -14.8257
18 C1a C 34.7210 -17.0030
19 C1a C 33.5269 -14.8959
20 C1y C 17.7594 -14.1293
21 C1x C 16.5185 -14.7730
22 C1x C 16.5713 -13.3743
BOND 23
1 1 2 1
2 1 3 2
3 1 4 1
4 2 5 2
5 3 6 1
6 4 7 1
7 5 8 1
8 7 9 1
9 8 10 1
10 9 11 1
11 9 12 1
12 10 13 1
13 11 14 1
14 13 15 1
15 14 16 1
16 15 17 1
17 16 18 1
18 16 19 1
19 17 20 1
20 20 21 1
21 20 22 1
22 6 8 2
23 21 22 1
|
|
» Japanese version
|
|